Literature DB >> 17878150

Zoledronic acid and secondary prevention of fractures.

Karim Anton Calis, Frank Pucino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878150     DOI: 10.1056/NEJMe078192

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Authors:  Matthew R Smith; Blair Egerdie; Narciso Hernández Toriz; Robert Feldman; Teuvo L J Tammela; Fred Saad; Jiri Heracek; Maciej Szwedowski; Chunlei Ke; Amy Kupic; Benjamin Z Leder; Carsten Goessl
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

2.  A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.

Authors:  Sharon M Moe; Neal X Chen; Christopher L Newman; Vincent H Gattone; Jason M Organ; Xianming Chen; Matthew R Allen
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.